Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Eric Angevin, John H. Strickler, Colin D. Weekes, Rebecca Suk Heist, Daniel Morgensztern, John J. Nemunaitis, Xiaolin Fan, Juliette Beaulieu, Monica Motwani, Daniel E. Afar, Louie Naumovski, Karen Kelly | ||||||||||||
Title | Phase I study of ABBV-399, a c-Met antibody-drug conjugate (ADC), as monotherapy and in combination with erlotinib in patients (pts) with non-small cell lung cancer (NSCLC) | ||||||||||||
|
|||||||||||||
URL | http://abstracts.asco.org/199/AbstView_199_183940.html | ||||||||||||
Abstract Text | J Clin Oncol 35, 2017 (suppl; abstr 2509) |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|